Cargando…

MEL-18, a tumor suppressor for aggressive breast cancer

Detalles Bibliográficos
Autores principales:	Lee, Jeong-Yeon, Kong, Gu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599214/ https://www.ncbi.nlm.nih.gov/pubmed/26158291

Ejemplares similares

DOT1L: a new therapeutic target for aggressive breast cancer
por: Lee, Jeong-Yeon, et al.
Publicado: (2015)

Expression of BMI-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer
por: Riis, Margit LH, et al.
Publicado: (2010)

The many-faced KSR1: a tumor suppressor in breast cancer
por: Zhang, Hua, et al.
Publicado: (2015)

BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer
por: Zhang, Xiao-Wei, et al.
Publicado: (2010)

UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer
por: Xiang, Gang, et al.
Publicado: (2022)

Comparative study of antidiabetic, bactericidal, and antitumor activities of MEL@AgNPs, MEL@ZnONPs, and Ag–ZnO/MEL/GA nanocomposites prepared by using MEL and gum arabic
por: Bakur, Abdelmoneim, et al.
Publicado: (2019)

Mel – Personal Reminiscence(†)
por: Taeusch, H. William
Publicado: (2014)

Tumor suppressors revival in CLL
por: Carrà, Giovanna, et al.
Publicado: (2017)

Mel Greaves: Cancer through the Lens of Evolution
Publicado: (2016)

Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma
por: Lu, You-Wei, et al.
Publicado: (2010)

Expression and Clinicopathological Significance of Mel-18 and Bmi-1 in Esophageal Squamous Cell Carcinoma
por: Ji, Huaijun, et al.
Publicado: (2017)

MEL scripting for Maya animators
por: Wilkins, Mark R, et al.
Publicado: (2005)

Professional MEL solutions for production
por: Mannens, Kevin, et al.
Publicado: (2009)

Autoregulation of the Escherichia coli melR promoter: repression involves four molecules of MelR
por: Samarasinghe, Shivanthi, et al.
Publicado: (2008)

Understanding Breast Cancer Aggressiveness and Its Implications in Diagnosis and Treatment
por: Afifi, Nader, et al.
Publicado: (2023)

Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome
por: Wang, Zhanwei, et al.
Publicado: (2019)

Tumor suppressor prostaglandin D(2)
por: Maeda, Shingo, et al.
Publicado: (2014)

Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness
por: Brivio, Simone, et al.
Publicado: (2017)

Classifying Heart-Sound Signals Based on CNN Trained on MelSpectrum and Log-MelSpectrum Features
por: Chen, Wei, et al.
Publicado: (2023)

Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis
por: Lee, Chanju, et al.
Publicado: (2022)

What do Steven Spielberg, Mel Gibson and Emperor Hadrian have in common? Frank’s sign and the link with coronary artery disease
por: Tsampasian, Vasiliki, et al.
Publicado: (2021)

Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer
por: Wang, Xiao-Feng, et al.
Publicado: (2016)

wMel limits zika and chikungunya virus infection in a Singapore Wolbachia-introgressed Ae. aegypti strain, wMel-Sg
por: Tan, Cheong Huat, et al.
Publicado: (2017)

Endotrophin – Linking Obesity with Aggressive Tumor Growth
por: Park, Jiyoung, et al.
Publicado: (2012)

Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives
por: Bioletto, Fabio, et al.
Publicado: (2022)

MEL scripting: a character rig in Maya
por: Maraffi, Chris
Publicado: (2009)

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?
por: Liu, Chia-Chia, et al.
Publicado: (2023)

circPSMC3: ceRNA and tumor suppressor
por: Lu, Chen, et al.
Publicado: (2019)

Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research
por: Kim, Min Young, et al.
Publicado: (2019)

PU.1 is a tumor suppressor for B cell malignancies
por: Okuno, Yutaka, et al.
Publicado: (2012)

DLC1: a tumor suppressor that regulates Rho signaling
por: Tripathi, Brajendra K., et al.
Publicado: (2017)

Mel-CAM Expression in Common Oral Carcinomas
por: Shamloo, Nafise, et al.
Publicado: (2020)

Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer
por: Jung, Yeonjoo, et al.
Publicado: (2015)

Structure and Mechanism of Action of the BRCA2 Breast Cancer Tumor Suppressor
por: Shahid, Taha, et al.
Publicado: (2014)

Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo
por: Wang, Jiansong, et al.
Publicado: (2019)

Molecular network of HCC aggressiveness
por: Kim, Sang Geon, et al.
Publicado: (2015)

MIR-491: CDKN2A tumor suppressor co-pilot
por: Moore, Lynette M., et al.
Publicado: (2015)

Miliary breast cancer brain metastasis: a rare and aggressive form of central nervous system metastasis
por: Mills, Matthew N., et al.
Publicado: (2020)

Tumor-suppressor activity of RRIG1 in breast cancer
por: Zhang, Guihong, et al.
Publicado: (2011)

The tumor suppressor function of STAT1 in breast cancer
por: Koromilas, Antonis E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qbq901t65vuo7v9fl8eorh9bfj